Delivery Order SPE2DB20D2014-SPE2DB24FB43T
Award Date
3/26/24
Potential Completion Date
3/27/24
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $2,257.96, is for the supply of Dupixent 300 mg/2 ml pens. The contract is a firm fixed price delivery order with a performance period through March 25, 2024. Amerisourcebergen Drug Corp holds a single-award indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,881.42 firm fixed price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period through March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award, valued at $3,418.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period extending through April 10, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award, valued at $20,602.38, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,298.24, is a delivery order for the provision of Dupixent 300 mg/2 ml pen, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of April 24, 2025. The award is not associated with a set-aside program, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $6,609.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a firm fixed price delivery order for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $10,874.27 firm fixed price delivery order is for the supply of the pharmaceutical drug Dupixent 300 mg/2 ml pen, with a period of performance through March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,605.29 firm fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The $54,622.76 delivery order contract is for the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract is a firm fixed-price arrangement with a completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,285.94, is a delivery order for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product. The contract is a firm fixed-price agreement with an ultimate completion date of April 28, 2025. This award is not associated with a set-aside program and is open to competition....